Internal Medicine · Pasadena, CA
NPI
1033219084
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1515 N Fair Oaks Ave
Pasadena, CA, 91103
Phone (626) 798-1111
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$609K
6,605 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Robert E Ladines prescribed most often to Medicare patients was Atorvastatin Calcium, with 340 prescriptions and refills. In total Robert E Ladines wrote 6,605 Medicare prescriptions that cost $609K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 340 | 348 | 112 | $4,313 |
| Amlodipine Besylate Generic | 334 | 353 | 92 | $2,585 |
| Levothyroxine Sodium Generic | 260 | 261 | 58 | $3,007 |
| Tamsulosin Hcl Generic | 229 | 237 | 65 | $3,017 |
| Metformin Hcl Generic | 205 | 219 | 65 | $1,825 |
| Losartan Potassium Generic | 165 | 168 | 41 | $1,769 |
| Furosemide Generic | 148 | 152 | 52 | $858 |
| Famotidine Generic | 134 | 135 | 30 | $1,874 |
| Metoprolol Tartrate Generic | 122 | 128 | 31 | $1,477 |
| Potassium Chloride Generic | 119 | 131 | 42 | $4,969 |
| Gabapentin Generic | 114 | 118 | 31 | $2,018 |
| Pantoprazole Sodium Generic | 112 | 119 | 51 | $2,014 |
| Levetiracetam Generic | 109 | 110 | 24 | $3,663 |
| Quetiapine Fumarate Generic | 107 | 115 | 40 | $2,327 |
| Omeprazole Generic | 106 | 107 | 38 | $1,076 |
Brand drugs: 856 claims; generic drugs: 5,623 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Robert E Ladines were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.